Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion type Assertion NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_head.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion description "[Because HDAC inhibition disrupts the chaperon function of heat shock protein (HSP) 90, we hypothesized that the combination of 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90, and the HIV protease inhibitor ritonavir would also act against renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_provenance.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion evidence source_evidence_literature NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_provenance.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion SIO_000772 22470109 NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_provenance.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion wasDerivedFrom befree-2016 NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_provenance.
- NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_assertion wasGeneratedBy ECO_0000203 NP972056.RAPpZIPsgzkqdBgLcDTW7Ov_VIoFPpR1sVvAHd8Oa-_QA130_provenance.